DE60235603D1 - Fusionsprotein mit gesteigerter in vivo Erythropoietin-Aktivität - Google Patents
Fusionsprotein mit gesteigerter in vivo Erythropoietin-AktivitätInfo
- Publication number
- DE60235603D1 DE60235603D1 DE60235603T DE60235603T DE60235603D1 DE 60235603 D1 DE60235603 D1 DE 60235603D1 DE 60235603 T DE60235603 T DE 60235603T DE 60235603 T DE60235603 T DE 60235603T DE 60235603 D1 DE60235603 D1 DE 60235603D1
- Authority
- DE
- Germany
- Prior art keywords
- increased
- fusion protein
- erythropoietin activity
- vivo
- vivo erythropoietin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000003951 Erythropoietin Human genes 0.000 title 1
- 108090000394 Erythropoietin Proteins 0.000 title 1
- 229940105423 erythropoietin Drugs 0.000 title 1
- 108020001507 fusion proteins Proteins 0.000 title 1
- 102000037865 fusion proteins Human genes 0.000 title 1
- 238000001727 in vivo Methods 0.000 title 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/524—Thrombopoietin, i.e. C-MPL ligand
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2001-0074975A KR100467750B1 (ko) | 2001-11-29 | 2001-11-29 | 생체내 에리스로포이에틴 활성이 증진된 융합단백질 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60235603D1 true DE60235603D1 (de) | 2010-04-22 |
Family
ID=36821313
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60235603T Expired - Lifetime DE60235603D1 (de) | 2001-11-29 | 2002-08-01 | Fusionsprotein mit gesteigerter in vivo Erythropoietin-Aktivität |
| DE10235248A Expired - Fee Related DE10235248B4 (de) | 2001-11-29 | 2002-08-01 | Fusionsprotein mit verstärkter in vivo-Aktivität von Erythropoietin |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE10235248A Expired - Fee Related DE10235248B4 (de) | 2001-11-29 | 2002-08-01 | Fusionsprotein mit verstärkter in vivo-Aktivität von Erythropoietin |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7098318B2 (de) |
| EP (1) | EP1319712B1 (de) |
| JP (1) | JP3860097B2 (de) |
| KR (1) | KR100467750B1 (de) |
| CN (1) | CN100390201C (de) |
| AR (1) | AR036384A1 (de) |
| AT (1) | ATE460483T1 (de) |
| AU (1) | AU2002300359B2 (de) |
| BR (1) | BRPI0203394B1 (de) |
| CA (1) | CA2394572C (de) |
| DE (2) | DE60235603D1 (de) |
| ES (1) | ES2339426T3 (de) |
| FR (1) | FR2832716B1 (de) |
| GB (1) | GB2382580B (de) |
| IT (1) | ITMI20021803A1 (de) |
| MX (1) | MXPA02008131A (de) |
| MY (1) | MY122935A (de) |
| NZ (1) | NZ520442A (de) |
| RU (1) | RU2225220C1 (de) |
| SG (1) | SG117416A1 (de) |
| TW (1) | TWI237056B (de) |
| WO (1) | WO2003046013A1 (de) |
| ZA (1) | ZA200206172B (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7345019B1 (en) * | 1999-04-13 | 2008-03-18 | The Kenneth S. Warren Institute, Inc. | Modulation of excitable tissue function by peripherally administered erythropoietin |
| US20030072737A1 (en) * | 2000-12-29 | 2003-04-17 | Michael Brines | Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| US7767643B2 (en) | 2000-12-29 | 2010-08-03 | The Kenneth S. Warren Institute, Inc. | Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| EP1670492A4 (de) * | 2003-09-29 | 2009-07-08 | Warren Pharmaceuticals Inc | Gewebeschützende zytokine zur behandlung und prävention von sepsis und bildung von adhäsionen |
| US7625564B2 (en) | 2006-01-27 | 2009-12-01 | Novagen Holding Corporation | Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| US20150038413A1 (en) | 2006-02-03 | 2015-02-05 | Opko Biologics Ltd. | Long-acting polypeptides and methods of producing and administering same |
| WO2007092252A2 (en) * | 2006-02-03 | 2007-08-16 | Modigene Inc | Long-acting polypeptides and methods of producing same |
| US20140113860A1 (en) | 2006-02-03 | 2014-04-24 | Prolor Biotech Ltd. | Long-acting polypeptides and methods of producing and administering same |
| US9249407B2 (en) | 2006-02-03 | 2016-02-02 | Opko Biologics Ltd. | Long-acting coagulation factors and methods of producing same |
| US8048849B2 (en) | 2006-02-03 | 2011-11-01 | Modigene, Inc. | Long-acting polypeptides and methods of producing same |
| US8946155B2 (en) | 2006-02-03 | 2015-02-03 | Opko Biologics Ltd. | Long-acting polypeptides and methods of producing and administering same |
| US10221228B2 (en) | 2006-02-03 | 2019-03-05 | Opko Biologics Ltd. | Long-acting polypeptides and methods of producing and administering same |
| US10351615B2 (en) | 2006-02-03 | 2019-07-16 | Opko Biologics Ltd. | Methods of treatment with long-acting growth hormone |
| US9458444B2 (en) | 2006-02-03 | 2016-10-04 | Opko Biologics Ltd. | Long-acting coagulation factors and methods of producing same |
| CA2720628A1 (en) | 2007-07-26 | 2009-01-29 | Novagen Holding Corporation | Fusion proteins having mutated immunoglobulin hinge region |
| CN101863982A (zh) * | 2009-04-17 | 2010-10-20 | 哈药集团生物工程有限公司 | 一种用于升高血小板的融合蛋白及其制备方法 |
| US9663778B2 (en) | 2009-07-09 | 2017-05-30 | OPKO Biologies Ltd. | Long-acting coagulation factors and methods of producing same |
| CN103864913A (zh) * | 2012-12-18 | 2014-06-18 | 联亚生技开发股份有限公司 | 重组蛋白 |
| US20160024181A1 (en) | 2013-03-13 | 2016-01-28 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
| US20150158926A1 (en) | 2013-10-21 | 2015-06-11 | Opko Biologics, Ltd. | Long-acting polypeptides and methods of producing and administering same |
| EP3310347B1 (de) | 2015-06-19 | 2021-08-04 | OPKO Biologics Ltd. | Gerinnungsfaktoren mit langzeitwirkung und verfahren zur herstellung davon |
| KR20240006077A (ko) | 2016-07-11 | 2024-01-12 | 옵코 바이오로직스 리미티드 | 지속성 응고 인자 vii 및 그 제조 방법 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3045539B2 (ja) * | 1989-02-21 | 2000-05-29 | ワシントン ユニバーシティ | 改変型生殖ホルモン |
| AU5355790A (en) * | 1989-04-19 | 1990-11-16 | Cetus Corporation | Multifunctional m-csf proteins and genes encoding therefor |
| US5856298A (en) * | 1989-10-13 | 1999-01-05 | Amgen Inc. | Erythropoietin isoforms |
| IL110669A (en) * | 1993-08-17 | 2008-11-26 | Kirin Amgen Inc | Erythropoietin analogs |
| SG47030A1 (en) * | 1994-01-03 | 1998-03-20 | Genentech Inc | Thrombopoietin |
| ITFI940106A1 (it) * | 1994-05-27 | 1995-11-27 | Menarini Ricerche Sud Spa | Molecola ibrida di formula gm-csf-l-epo o epo-l-gm-csf per la stimolaz ione eritropoietica |
| CA2212006A1 (en) * | 1995-02-03 | 1996-08-08 | G.D. Searle & Co. | Novel c-mpl ligands |
| AU8182298A (en) * | 1997-07-10 | 1999-02-08 | Beth Israel Deaconess Medical Center | Recombinant erythropoietin / immunoglobulin fusion proteins |
| US6242570B1 (en) * | 1997-07-10 | 2001-06-05 | Beth Israel Deaconess Medical Center | Production and use of recombinant protein multimers with increased biological activity |
| ES2297889T3 (es) * | 1997-07-14 | 2008-05-01 | Bolder Biotechnology, Inc. | Derivados de hormona de crecimiento y proteinas relacionadas. |
| US6342220B1 (en) * | 1997-08-25 | 2002-01-29 | Genentech, Inc. | Agonist antibodies |
| WO1999057147A1 (fr) * | 1998-04-30 | 1999-11-11 | Kirin Brewery Company, Limited | Mutants de la thrombopoietine humaine |
| EP1200124B1 (de) * | 1999-07-13 | 2008-09-10 | Bolder Biotechnology, Inc. | Erythropoietin immunglobulin fusionsproteine |
| JP2003514552A (ja) * | 1999-11-12 | 2003-04-22 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | 改善された性質を有するエリトロポエチンの形態 |
-
2001
- 2001-11-29 KR KR10-2001-0074975A patent/KR100467750B1/ko not_active IP Right Cessation
-
2002
- 2002-07-24 CA CA002394572A patent/CA2394572C/en not_active Expired - Fee Related
- 2002-07-26 TW TW091116686A patent/TWI237056B/zh not_active IP Right Cessation
- 2002-07-26 WO PCT/KR2002/001420 patent/WO2003046013A1/en active Search and Examination
- 2002-07-30 MY MYPI20022857A patent/MY122935A/en unknown
- 2002-07-30 AU AU2002300359A patent/AU2002300359B2/en not_active Ceased
- 2002-07-30 NZ NZ520442A patent/NZ520442A/en not_active IP Right Cessation
- 2002-08-01 DE DE60235603T patent/DE60235603D1/de not_active Expired - Lifetime
- 2002-08-01 ES ES02016953T patent/ES2339426T3/es not_active Expired - Lifetime
- 2002-08-01 AT AT02016953T patent/ATE460483T1/de active
- 2002-08-01 SG SG200204673A patent/SG117416A1/en unknown
- 2002-08-01 DE DE10235248A patent/DE10235248B4/de not_active Expired - Fee Related
- 2002-08-01 EP EP02016953A patent/EP1319712B1/de not_active Expired - Lifetime
- 2002-08-02 FR FR0209867A patent/FR2832716B1/fr not_active Expired - Lifetime
- 2002-08-02 ZA ZA200206172A patent/ZA200206172B/xx unknown
- 2002-08-06 GB GB0218252A patent/GB2382580B/en not_active Expired - Fee Related
- 2002-08-08 IT IT001803A patent/ITMI20021803A1/it unknown
- 2002-08-20 BR BRPI0203394A patent/BRPI0203394B1/pt not_active IP Right Cessation
- 2002-08-21 MX MXPA02008131A patent/MXPA02008131A/es active IP Right Grant
- 2002-08-23 CN CNB021301557A patent/CN100390201C/zh not_active Expired - Fee Related
- 2002-08-29 US US10/230,454 patent/US7098318B2/en not_active Expired - Lifetime
- 2002-08-30 RU RU2002123438/15A patent/RU2225220C1/ru not_active IP Right Cessation
- 2002-08-30 JP JP2002253938A patent/JP3860097B2/ja not_active Expired - Fee Related
- 2002-08-30 AR ARP020103279A patent/AR036384A1/es not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60235603D1 (de) | Fusionsprotein mit gesteigerter in vivo Erythropoietin-Aktivität | |
| NO20033247L (no) | Bifunksjonelle fusjonsproteiner med glukocerebrosidaseaktivitet | |
| AU2002300734A1 (en) | Fusion protein having enhanced in vivo erythropoietin activity | |
| CY2014040I1 (el) | Πρωτεϊνη συντηξης αλβουμινης | |
| LTC1641823I2 (lt) | GLP-1 analogo sulieti baltymai | |
| IL166751A0 (en) | Modified transferin-antibody fusion proteins | |
| DK2236152T3 (da) | Albuminfusionsproteiner | |
| EP1594530A4 (de) | Albuminfusionsproteine | |
| DE60234432D1 (de) | Umbales zwischenwirbelfusionsverfahren | |
| PL362324A1 (en) | Artificial fusion proteins with reduced immunogenicity | |
| ATE535602T1 (de) | Modifiziertes insulin mit reduzierter immunogenität | |
| DE60135100D1 (de) | E mit ultradünnem elektrolyten | |
| BR0307500B1 (pt) | sachÊ com trÊs soldas. | |
| AU2002300359A1 (en) | Fusion Protein Having Enhanced in vivo Activity of Erythropoietin | |
| ATE439376T1 (de) | Gag-bindende proteine | |
| DE60213194D1 (de) | Haltenadel mit flügel | |
| DE60238111D1 (de) | Viszeralfettmesser mit tonometer | |
| DE60229399D1 (de) | Hgf-hydrogel-zubereitungen mit verzögerter freisetzung | |
| NO20021275D0 (no) | Transgent produserte fusjonsproteiner | |
| DE60236774D1 (de) | Festkörperlaser mit Ytterbium-YAG Verbundmaterial | |
| DE60143148D1 (de) | En mit honigwaben | |
| DE60211549D1 (de) | Geformte zuleitung mit elektroden | |
| DE10391971D2 (de) | Steckerbrücke mit Hohlstift | |
| DE10082298D2 (de) | Chimäre Proteine | |
| NO20021244L (no) | Subenhet-optimaliserte fusjonsproteiner |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |